Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sinopharm Group Co's Enterprise Value is $16,555 Mil.
Sinopharm Group Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $2,405 Mil. Therefore, Sinopharm Group Co's EV-to-EBIT ratio for today is 6.88.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sinopharm Group Co's Enterprise Value is $16,555 Mil.
Sinopharm Group Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $3,008 Mil. Therefore, Sinopharm Group Co's EV-to-EBITDA ratio for today is 5.50.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sinopharm Group Co's Enterprise Value is $16,555 Mil.
Sinopharm Group Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $80,887 Mil. Therefore, Sinopharm Group Co's EV-to-Revenue ratio for today is 0.20.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Sinopharm Group Co (OTCPK:SHTDF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sinopharm Group Co's current Enterprise Value is $16,555 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $2,405 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sinopharm Group Co's current Enterprise Value is $16,555 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $3,008 Mil.
Sinopharm Group Co's current Enterprise Value is $16,555 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $80,887 Mil.
Sinopharm Group Co's current Enterprise Value is $16,555 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $2,100 Mil.
Sinopharm Group Co's current Enterprise Value is $16,555 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $1,872 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co Enterprise Value Related Terms
Sinopharm Group Co Enterprise Value Historical Data
* Premium members only.
The historical data trend for Sinopharm Group Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHTDF vs MCK, COR, CAH: Enterprise Value Comparison
For the Medical Distribution subindustry, Sinopharm Group Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sinopharm Group Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co (SHTDF) has a Enterprise Value of $16,555 Mil as of Jun. 24, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sinopharm Group Co and its competitors.
Is Sinopharm Group Co's Enterprise Value too high?
Sinopharm Group Co's current Enterprise Value is $16,555 Mil. Overall, Sinopharm Group Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Group Co's Enterprise Value compare to MCK and COR?
Sinopharm Group Co's Enterprise Value of $16,555 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sinopharm Group Co and its competitors. Sinopharm Group Co's current Enterprise Value is $16,555 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Group Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Group Co (SHTDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.03, compared to a current price of $2.29 — trading 24.5% below its estimated fair value. The current Enterprise Value is $16,555 Mil. Sinopharm Group Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Sinopharm Group Co (SHTDF), the current Enterprise Value is $16,555 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopharm Group Co (SHTDF) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopharm Group Co stock appears to be undervalued.
The current stock price of $2.29 is trading 24.5% below its estimated GF Value™ of $3.03.
GuruFocus considers Sinopharm Group Co to be Modestly Undervalued.
Key valuation signals for SHTDF:
Enterprise Value: $16,555 Mil
GF Value™: $3.03 vs. price of $2.29 (24.5% below fair value)
No single metric tells the full story. See the SHTDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
78GF Score
Get the complete analysis for SHTDF
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHTDF has been successfully added to your 
